• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical-Pathological Conference Series from the Medical University of Graz : Case No 183: A 57-year-old farmer with fever, cough, maculopapular rash and bicytopenia.

作者信息

Fabian Elisabeth, Gornicec Maximilian, Kneidinger Nikolaus, Wölfler Albert, Moazedi-Fürst Florentine, Puseljic Marijan, Fuchsjäger Michael, Krause Robert, Krejs Guenter J

机构信息

Department of Internal Medicine II, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems on the Danube, Austria.

Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

出版信息

Wien Klin Wochenschr. 2025 Sep 23. doi: 10.1007/s00508-025-02586-8.

DOI:10.1007/s00508-025-02586-8
PMID:40986038
Abstract
摘要

相似文献

1
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 183: A 57-year-old farmer with fever, cough, maculopapular rash and bicytopenia.格拉茨医科大学临床病理会议系列：病例编号183：一名57岁农民，伴有发热、咳嗽、斑丘疹和双血细胞减少症。
Wien Klin Wochenschr. 2025 Sep 23. doi: 10.1007/s00508-025-02586-8.
2
Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.伴 VEXAS 综合征骨髓增生异常综合征患者接受阿扎胞苷治疗获得成功。
Int J Hematol. 2023 Jun;117(6):919-924. doi: 10.1007/s12185-023-03532-y. Epub 2023 Jan 14.
3
Vexas Syndrome in a Moroccan Patient: The Story of a Two-Year Diagnostic Lag.一名摩洛哥患者的Vexas综合征：两年诊断延迟的故事。
Eur J Case Rep Intern Med. 2025 Jun 13;12(7):005419. doi: 10.12890/2025_005419. eCollection 2025.
4
Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature.JAK抑制在VEXAS综合征治疗中的前景：病例报告及文献综述
Open Access Rheumatol. 2025 Jul 21;17:147-156. doi: 10.2147/OARRR.S531094. eCollection 2025.
5
Hairy Cell Leukaemia with an Uncommon Pulmonary Presentation: A Case Report and Review of the Literature.具有罕见肺部表现的毛细胞白血病：一例报告并文献复习
Eur J Case Rep Intern Med. 2025 Jun 3;12(7):005389. doi: 10.12890/2025_005389. eCollection 2025.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方：益处与风险
7
Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study.VEXAS综合征患者的治疗结果：一项回顾性队列研究。
Lancet Rheumatol. 2025 May 21. doi: 10.1016/S2665-9913(25)00034-7.
8
VEXAS syndrome-associated tumefactive demyelination.VEXAS综合征相关的肿胀性脱髓鞘病变
J Neurol. 2025 Jul 12;272(8):506. doi: 10.1007/s00415-025-13239-1.
9
Immediate versus delayed versus no antibiotics for respiratory infections.即刻与延迟用与不用抗生素治疗呼吸道感染。
Cochrane Database Syst Rev. 2023 Oct 4;10(10):CD004417. doi: 10.1002/14651858.CD004417.pub6.
10
Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review.空泡、E1 酶、X 连锁、自身炎症、体细胞（VEXAS）综合征的临床特征、疾病轨迹和治疗：系统评价。
Rheumatol Int. 2024 Jul;44(7):1219-1232. doi: 10.1007/s00296-023-05513-0. Epub 2023 Dec 21.

本文引用的文献

1
[VEXAS Syndrome].[VEXAS综合征]
Rev Prat. 2025 Feb;75(2):196-200.
2
dysfunction in VEXAS and cancer.VEXAS 相关功能障碍与癌症。
Oncotarget. 2024 Sep 30;15:644-658. doi: 10.18632/oncotarget.28646.
3
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.靶向治疗在 VEXAS 综合征中的疗效和安全性：来自 FRENVEX 的回顾性研究。
Ann Rheum Dis. 2024 Sep 30;83(10):1358-1367. doi: 10.1136/ard-2024-225640.
4
Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.VEXAS 综合征患者大队列骨髓活检结果的全面形态学特征：52 例患者 111 份骨髓样本的单机构纵向研究。
Am J Clin Pathol. 2024 Jun 3;161(6):609-624. doi: 10.1093/ajcp/aqad186.
5
Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports.比较 VEXAS 综合征男性和女性患者的临床特征：来自患者报告文献分析的数据。
Rheumatology (Oxford). 2024 Oct 1;63(10):2694-2700. doi: 10.1093/rheumatology/keae123.
6
Shared and distinct mechanisms of UBA1 inactivation across different diseases.UBA1 失活在不同疾病中的共享和独特机制。
EMBO J. 2024 May;43(10):1919-1946. doi: 10.1038/s44318-024-00046-z. Epub 2024 Feb 15.
7
Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond.骨髓祖细胞中的空泡：VEXAS 综合征及其他。
Lancet Haematol. 2024 Feb;11(2):e160-e167. doi: 10.1016/S2352-3026(23)00375-7.
8
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation.VEXAS 综合征的特征为炎性体激活和单核细胞失调。
Nat Commun. 2024 Jan 30;15(1):910. doi: 10.1038/s41467-024-44811-4.
9
VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.VEXAS 综合征：临床表现、诊断与治疗。
Reumatol Clin (Engl Ed). 2024 Jan;20(1):47-56. doi: 10.1016/j.reumae.2023.12.004. Epub 2023 Dec 29.
10
Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry.VEXAS 综合征患者的严重感染：法国 VEXAS 登记处的数据。
Ann Rheum Dis. 2024 Feb 15;83(3):372-381. doi: 10.1136/ard-2023-224819.